Individual and institutional investors as well as advisors are invited to log-on to LifeSciencesInvestorForum.com to view presentations
NEW YORK, Dec. 21, 2020 (GLOBE NEWSWIRE) — Life Sciences Investor Forum today announced that the presentations from the December 17th conference are now available for on-demand viewing at LifeSciencesInvestorForum.com.
This virtual event showcased live company presentations and interactive discussions focused on the life sciences industry. The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download shareholder materials from the company’s “virtual trade booth”.
REGISTER OR LOGIN AT:
https://bit.ly/2Wqsir2
December 17
th
Presenting Companies:
|
Company Name |
Ticker(s) |
| Kane Biotech Inc. |
OTCQB: KNBIF | TSX-V: KNE |
|
Theralase Technologies Inc. |
OTCQB: TLTFF | TSX-V: TLT |
| Caladrius Biosciences, Inc. |
NASDAQ: CLBS |
|
Pressure BioSciences, Inc. |
OTCQB: PBIO |
| HLS Therapeutics Inc. |
TSX: HLS |
| Bionexus Gene Lab Corp. |
OTCQB: BGLC |
| VolitionRx Limited |
NYSE AMERICAN: VNRX |
| XPhyto Therapeutics Corp. |
OTCQB: XPHYF | CSE: XPHY | FSE: 4XT |
| Avicanna Inc. |
OTCQX: AVCNF | TSX: AVCN |
To facilitate investor relations scheduling and for more information about the program, please visit
www.lifesciencesinvestorforum.com
.
About Life Sciences Investor Forum
Life Sciences Investor Forum is the leading proprietary investor conference series that provides an interactive forum for Life Sciences companies to meet with and present directly to investors.
A real-time solution for investor engagement, Life Sciences Investor Forum is powered by Intrado Digital Media and specifically designed for more efficient investor access. Replicating the look and feel of on-site investor conferences, Life Sciences Investor Forum combines leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.
CONTACT
Life Sciences Investor Forum
John M. Viglotti
SVP Corporate Services, Investor Access
(212) 220-2221
[email protected]
